Richard Scolyer leaves a unique legacy of pioneering brain cancer research
Scolyer captured the world’s attention when he volunteered for a world-first experimental treatment for brain cancer. He died on Sunday night, aged 59.
Original Source
Read the full article at Theconversation →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.